GH Research PLC
GHRS · XNASCIK 1855129fmd_1DD5D9W0YXG9AF4T0ZWS7BAB15Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2025, 18 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Research and development | 0 | 0 | 9 | 20 | 30 | 35 | 39 |
| Selling, general and administrative | 0 | 0 | 7 | 10 | 11 | 15 | 22 |
| Operating income | (0) | (0) | (15) | (31) | (41) | (50) | (61) |
| Interest expense | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Income before taxes | (0) | (0) | (9) | (22) | (36) | (39) | (48) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (0) | (0) | (9) | (22) | (36) | (39) | (48) |
| Net income | (0) | (0) | (9) | (22) | (36) | (39) | (48) |